Newron Pharmaceuticals SpA (FRA:NP5) FCF Margin % : -127.42% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Newron Pharmaceuticals SpA's Free Cash Flow for the six months ended in Dec. 2023 was €-4.54 Mil. Newron Pharmaceuticals SpA's Revenue for the six months ended in Dec. 2023 was €3.56 Mil. Therefore, Newron Pharmaceuticals SpA's FCF Margin % for the quarter that ended in Dec. 2023 was -127.42%.

As of today, Newron Pharmaceuticals SpA's current FCF Yield % is -5.12%.

The historical rank and industry rank for Newron Pharmaceuticals SpA's FCF Margin % or its related term are showing as below:

FRA:NP5' s FCF Margin % Range Over the Past 10 Years
Min: -643.64 Med: -305.05 Max: -63.04
Current: -112.08

During the past 13 years, the highest FCF Margin % of Newron Pharmaceuticals SpA was -63.04%. The lowest was -643.64%. And the median was -305.05%.

FRA:NP5's FCF Margin % is ranked better than
53.35% of 1046 companies
in the Biotechnology industry
Industry Median: -145.305 vs FRA:NP5: -112.08

Newron Pharmaceuticals SpA FCF Margin % Historical Data

The historical data trend for Newron Pharmaceuticals SpA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA FCF Margin % Chart

Newron Pharmaceuticals SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-312.97

-297.13

-198.98

-182.31

-112.08

Newron Pharmaceuticals SpA Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-87.54	-199.26	-167.62	-102.13	-127.42

Competitive Comparison of Newron Pharmaceuticals SpA's FCF Margin %

For the Biotechnology subindustry, Newron Pharmaceuticals SpA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newron Pharmaceuticals SpA's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Newron Pharmaceuticals SpA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Newron Pharmaceuticals SpA's FCF Margin % falls into.

Newron Pharmaceuticals SpA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Newron Pharmaceuticals SpA's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-10.151	/	9.057
	=	-112.08 %

Newron Pharmaceuticals SpA's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-4.54	/	3.563
	=	-127.42 %

Newron Pharmaceuticals SpA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA (FRA:NP5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (FRA:NP5) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

NWPHF:USA NP5:Germany NWRN:Switzerland

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Newron Pharmaceuticals SpA (FRA:NP5) Headlines

No Headlines